(2022) How To Code Tinea Pedis ICD 10 – List With Codes & Guidelines
This article will outline the causes, symptoms, diagnosis, treatment and the ICD 10 CM code for Tinea Pedis.
Tinea Pedis ICD 10 Causes
Tinea Pedis ICD 10 (Athletes foot) is caused by the same type of fungus that causes ringworms and jockeys. Wet socks and shoes in warm, damp conditions promote their growth. Tinea Pedis ICD 10 are highly contagious and spread through contact with an infected person or contact with contaminated surfaces such as towels, floors and shoes. Patients at high risk for Tinea Pedis ICD 10 are people who wear damp socks, tight shoes, share mats, carpets, bed linen, clothing or shoes with fungal infections or walk in public areas where athlete’s feet may spread, such as changing rooms, saunas, pools, shared bathrooms and showers.
Tinea Pedis ICD 10 Symptoms
There are many possible symptoms of Tinea Pedis ICD 10, including:
- burning on the soles of feet
- blisters on the feet
- exfoliating the skin on the foot (soles of the feet)
- dry skin around the soles or sides of the feet (raw skin)
- feet that are discolored
- thick toenails (or toenails pulled out of the nail bed)
Tinea Pedis ICD 10 Diagnosis
In order to confirm a diagnosis and rule out other diseases, doctors take abrasions and skin samples from the foot, which are examined in a laboratory.
Tinea Pedis ICD 10 Treatment
Tinea Pedis ICD 10 can be treated with topical or systemic prescription therapy. Systemic oral medications (e.g. Griseofulvin, itraconazole, ketoconazole and terbinafine) carry the possibility of side effects such as diarrhoea and rash, which makes them an attractive first therapeutic choice. When recommending over-the-counter products, pharmacists emphasize the importance of adhering to a regimen where the substance is used as indicated on the label and completing the full course of treatment.
Non-prescription treatments for Tinea Pedis ICD 10 are divided into three generations of successor products that offer significant benefits.
- The first generation includes: clotrimazole (crux cream, lotrimin AF cream), miconazole, cruex spray powder, desenex powder, lotremin AF powder, micrin spray liquid, tolnaftate, lamisil AF defence powder and cream spray. Patients are instructed to use these products once they have been used for at least four weeks. Unless otherwise stated, patients must be older than 2 years. The products are bacteriostatic, which may explain their long application time. They are not fungicidal because they interrupt the development of membranes that allow fungal cells to grow. The label states that the products cure tinea pedis ICD 10, but show no difference in effectiveness between the three subtypes.
- The second generation of antifungals for Tinea Pedis ICD 10 contains two ingredients: topical butenafine and Terbinafine. Topical butensafine is a synthetic fungistatic, fungicidal benzyl amine, and Terbinafin is a fungicidal allylamine. Of the three active substances in this class, Tolnaftat is the only active ingredient approved to prevent annual recurrence, but patients with annual relapses may not achieve the promised cure, making a more effective product preferable. These two substances deserve to be considered separately, because although they promise a cure in a relatively short time, they are not safe for patients under the age of 12.
- Butenafine and Lotrimin Ultra-Cream are also known for use in patients with Tinea Pedis ICD 10. These creams heal Tinea Pedis ICD 10 in 1 week up to 4 weeks if the patient takes them daily. The pharmacist advises patients to apply the creams morning and evening. Topical Terbinafin and Lamisil Cream (a spray-on-pump solution) can heal soles in interdigital form within a week.
ICD 10 Code For Tinea Pedis
ICD 10 CM B35.3 Tinea pedis